The shares of both of these large companies look attractive, technically-speaking.
Visa Inc. (V) and Edward Lifesciences (EW)
from Shortex Market Letter
Visa Inc (V)
TODAY’S 52wk H. 70.69 52wk L. 48.80
Mkt Cap: $169.72B, EPS 2.26, P/E: 30.20
DIV/YLD: 0.48(0.70%)
Visa Inc. (V) is the global operator of retail electronic payments network. The credit card issuer, “Visa”, is in negotiation to purchase London-based Visa-Europe, a cooperative entity composing of over 3,700 European Banks. (European license recorded $246M in net income in 2014.)
In correction/retraction since Dec ’14. (67-61), to (69-64), to (69-65), to (70-68), upperhead resistance of (69-70).
BUYING RANGE: 65-70
NR TERM OBJ: 78
INTERMED OBJ: 89
STOP LOSS: 64
Edward Lifesciences (EW)
52wk H. 150.41 52wk L. 78.12
Mkt Cap: $13.83B, EPS: 8.03 P/E: 16.02
Edward Lifesciences (EW) is the global provider of technology for treatment of heart disease and critically ill patients. The company voluntarily implemented a temporary pause on the enrollment of its experimental study on Fortis Mitral heart values: implanted via catheters instead of open-heart surgery.
Falling from the high of 150 set on 03/16/15 @ (150-137), to (142-122). Reversal @ (122-133) to meet primary resistance @ (135-137) and secondary resistance @ (141-145). Volatile.
BUYING RANGE: 128-132
NR TERM OBJ: 149
INTERMED OBJ: 161
STOP LOSS: 124
Joseph Parnes, Shortex Market Letter, www.shortex.com, 800-877-6555, May 27, 2015